Drugs / Paclitaxel polyglumex
last change Jan 2008 re-read 3 minutes ago

Paclitaxel polyglumex

also known as Xyotax
Developed for
prostate cancer
Investigated by
Cellular Therapeutics · The Methodist Hospital Research Institute

Trials 1

20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00446836 Mar 2005 → Nov 2007 prostate cancer The Methodist Hospital Research Institute Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Paclitaxel polyglumex ClinicalTrials.gov intervention name — accepted as the source's own label NCT00446836 ↗
Known as Xyotax “Paclitaxel polyglumex (Xyotax)” NCT00446836 ↗